Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
From the official U.S. FDA label for newcastle disease (ranikhet disease) vaccine, the active ingredient registered with NAFDAC.
Supports the immune systems response to Lyme disease symptoms.* * Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Supports the immune systems response to Lyme disease symptom
iF PREGNANT OR BREAST-FEEDING, ask a health care professional before use. If symptoms worsen or persist for more than a week, discontinue use and contact a doctor. KEEP OUT OF REACH OF CHILDREN.
Add the expiry date on your pack for a full Trust Score.
R2B Strain (Ranikhet Disease) Vaccine contains Newcastle disease (Ranikhet disease) vaccine, Live (see Composition), as freeze-dried powder for injection, according to its NAFDAC registration record.
Yes. R2B Strain (Ranikhet Disease) Vaccine is listed on the NAFDAC register under registration number A6-0364, and its registration is active as of 27 October 2026.
No WHO falsified or substandard medical product alert currently matches R2B Strain (Ranikhet Disease) Vaccine in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A6-0364, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
Supports the immune systems response to Lyme disease symptoms.* * Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. (Summarised from the official U.S. FDA label for newcastle disease (ranikhet disease) vaccine. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.